Insights | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Webinar | April 14, 2022

Viewing the Orange Book Under a Microscope: The Regulatory Framework & its Implications for Branded Drug Makers

Webinar | December 09, 2021

Hatch-Waxman 2021 Year in Review

Blog | July 10, 2020

Chief Judge Stark Dismisses Hatch-Waxman Case after Paragraph IV to Paragraph III Conversion

Blog | June 22, 2020

FDA Seeks to Modernize the Orange Book

Article | May 22, 2020

How Pandemic-Related Delays Affect Hatch-Waxman Litigants

IP Law Essentials | April 22, 2020

Patent Local Rules: Knowing Them Well Can Make Litigating Your Case Smoother

Blog | October 09, 2017

Mayo at Five: Are Traditional Method of Treatment Claims in Danger Under Section 101?

Blog | September 06, 2017

Mayo at Five: Eligibility of Diagnostic Method Claims

Blog | February 16, 2016

Diagnostics Patent Eligibility: A Turning Point Approaches